Poster
Mepolizumab Improves Health-Related Quality of Life for Patients With Chronic Rhinosinusitis With Nasal Polyps: Data From the SYNAPSE Study
Author
Lee SE
Condition
Chronic Rhinosinusitis with Nasal Polyps
Drug target
IL-5
Source url
s3://convoke-optic-posters/2024-05-10/5_Lee_205687_AAAAI-2021_poster.pdf
10 organizations
1 product
Product
MepolizumabOrganization
Respiratory Patient Centered Outcomes, GSKOrganization
Eastern Virginia Medical SchoolOrganization
John Hopkins School of MedicineOrganization
Global Medical Affairs, GSKOrganization
Respiratory Therapeutic Area, GSKOrganization
Patient-Centred Outcomes, Adelphi ValuesOrganization
Clinical Statistics, GSK